Federated Hermes’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-4,184
Closed -$1.36M – 2166
2024
Q1
$1.36M Sell
4,184
-295
-7% -$72.4K ﹤0.01% 1031
2023
Q4
$854K Buy
4,479
+364
+9% +$68.8K ﹤0.01% 1187
2023
Q3
$819K Sell
4,115
-35,100
-90% -$8.3M ﹤0.01% 1191
2023
Q2
$11.2M Buy
39,215
+33,555
+593% +$9.32M 0.03% 519
2023
Q1
$1.23M Sell
5,660
-11,626
-67% -$2.27M ﹤0.01% 1107
2022
Q4
$3.55M Sell
17,286
-59,745
-78% -$15.1M 0.01% 754
2022
Q3
$21.4M Buy
77,031
+70,655
+1,108% +$18M 0.06% 365
2022
Q2
$1.22M Buy
6,376
+2,520
+65% +$445K ﹤0.01% 1065
2022
Q1
$800K Sell
3,856
-143,526
-97% -$23.7M ﹤0.01% 1318
2021
Q4
$26.3M Sell
147,382
-60,162
-29% -$11.9M 0.05% 431
2021
Q3
$42.7M Buy
207,544
+13,434
+7% +$2.64M 0.08% 314
2021
Q2
$36.8M Buy
194,110
+139,488
+255% +$22.8M 0.07% 347
2021
Q1
$7.12M Sell
54,622
-201,205
-79% -$24.1M 0.01% 759
2020
Q4
$26.5M Buy
255,827
+61,171
+31% +$5.3M 0.05% 394
2020
Q3
$14.8M Buy
+194,656
New +$11M 0.03% 478

Other funds holding SWAV

Federated Hermes's SWAV Position: Q2 2024 in Review

Federated Hermes sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 4,184 shares — an estimated $1.36M sold.

Federated Hermes first reported a position in SWAV in Q3 2020 and held it in 15 quarters. The position peaked at $42.7M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Federated Hermes reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Federated Hermes sold 4,184 Shockwave Medical shares in Q2 2024, an estimated $1.36M.
  • Federated Hermes first reported a position in Shockwave Medical in Q3 2020 and held it in 15 quarters.
  • Federated Hermes's Shockwave Medical position peaked at $42.7M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.